DOI QR코드

DOI QR Code

백서 두개골결손모델에서 실크단백과 골형성단백 이식체가 골재생에 미치는 영향

The effect of silk fibroin and rhBMP-2 on bone regeneration in rat calvarial defect model

  • 남정훈 (한림대학교 의과대학 강남성심병원 구강악안면외과학교실) ;
  • 노경록 (한림대학교 의과대학 강남성심병원 구강악안면외과학교실) ;
  • 방은오 (한림대학교 의과대학 강남성심병원 구강악안면외과학교실) ;
  • 유우근 (한림대학교 의과대학 강남성심병원 구강악안면외과학교실) ;
  • 강응선 (한림대학교 의과대학 강남성심병원 강악안면외과학교실) ;
  • 권해용 (농촌진흥청) ;
  • 김성곤 (강릉원주대학교 치과대학 구강악안면외과학교실) ;
  • 박영주 (한림대학교 의과대학 강남성심병원 구강악안면외과학교실)
  • Nam, Jeong-Hun (Department of Oral and Maxillofacial Surgery, Kangnam Sacred Heart Hospital, College of Medicine) ;
  • Noh, Kyung-Lok (Department of Oral and Maxillofacial Surgery, Kangnam Sacred Heart Hospital, College of Medicine) ;
  • Pang, Eun-O (Department of Oral and Maxillofacial Surgery, Kangnam Sacred Heart Hospital, College of Medicine) ;
  • Yu, Woo-Geun (Department of Oral and Maxillofacial Surgery, Kangnam Sacred Heart Hospital, College of Medicine) ;
  • Kang, Eung-Sun (Department of Oral and Maxillofacial Surgery, Kangnam Sacred Heart Hospital, College of Medicine) ;
  • Kweon, Hae-Yong (National Academy of Agricultural Science, Rural Development Administration) ;
  • Kim, Seong-Gon (Department of Oral and Maxillofacial Surgery, College of Dentistry, Gangneung-Wonju National University) ;
  • Park, Young-Ju (Department of Oral and Maxillofacial Surgery, Kangnam Sacred Heart Hospital, College of Medicine)
  • 투고 : 2010.06.07
  • 심사 : 2010.10.19
  • 발행 : 2010.10.29

초록

Introduction: This study evaluated the capability of silk fibroin (SF) and recombinant human bone morphogenetic protein-2 loaded SF (SF-BMP) as a bone defect replacement matrix when grafted in a calvarial bone defect of rats in vivo. Materials and Methods: A total 70 calvarial critical size defects (5.0 mm in diameter) made on 35 adult female Sprague-Dawley rats were used in this study. The defects were transplanted with (1) rhBMP-2 loaded silk fibroin graft (SF-BMP: 0.8+$10\;{\mu}g$), (2) Silk fibroin (SF: $10\;{\mu}g$), and (3) no graft material (Raw). The samples were evaluated with soft x-rays, alkaline phosphatase activity, calcium/phosphate quantification, histological and histomorphometric analysis at postoperative 4 and 8 weeks. Results: The SF-BMP group ($48.86{\pm}14.92%$) had a significantly higher mean percentage bone area than the SF group ($24.96{\pm}11.01%$) at postoperative 4 weeks.(P<0.05) In addition, the SF-BMP group ($40.01{\pm}12.43%$) had a higher % bone area at postoperative 8 weeks than the SF group ($33.26{\pm}5.15%$). The mean ratio of gray scale levels to the host bone showed that the SF-BMP group ($0.67{\pm}0.08$) had a higher mean ratio level than the SF group ($0.61{\pm}0.09$) at postoperative 8 weeks. These differences were not statistically significant.(P=0.168 and P=0.243, respectively) The ratio of the calcium and phosphate contents of the SF-BMP ($0.93{\pm}0.22$) group was lower than that of the SF ($1.90{\pm}1.42$) group at postoperative 4 weeks. However, the SF-BMP group ($0.75{\pm}0.31$) had a higher Ca/$PO_4$ ratio than the SF ($0.68{\pm}0.04$) at postoperative 8 weeks. These differences were not statistically significant.(P=0.126 and P=0.627, respectively) For the bone-specific alkaline phosphatase (ALP) activity, which is recognized as a reliable indicator of the osteoblast function, the SF-BMP ($23.71{\pm}8.60\;U/L$) groups had a significantly higher value than the SF group ($12.65{\pm}6.47\;U/L$) at postoperative 4 weeks.(P<0.05) At postoperative 8 weeks, the SF-BMP ($21.65{\pm}10.02\;U/L$) group had a lower bone-specific ALP activity than the SF group ($16.72{\pm}7.35\;U/L$). This difference was not statistically significant.(P=0.263) For the histological evaluation, the SF-BMP group revealed less inflammation, lower foreign body reactions and higher bone healing than the SF group at postoperative 4 and 8 weeks. The SF group revealed more foreign body reactions at postoperative 4 weeks. However, this immunogenic reaction decreased and the remnant of grafted material was observed at postoperative 8 weeks. For histomorphometric analysis, the SF-BMP group had a significantly longer bone length to total length ratio than those of the SF group at postoperative 4 and 8 weeks.(P<0.05) Conclusion: The rhBMP-2 loaded silk fibroin graft revealed fewer immunoreactions and inflammation as well as more new bone formation than the pure silk fibroin graft. Therefore, silk fibroin may be a candidate scaffold for tissue engineered bone regeneration.

키워드

참고문헌

  1. Urist MR. Bone formation by autoinduction. Science 1965;150: 893-9. https://doi.org/10.1126/science.150.3698.893
  2. Mizutani H, Urist MR. The nature of bone morphogenetic protein (BMP) fractions derived from bovine bone matrix gelatin. Clin Orthop Relat Res 1981;171:213-23.
  3. Sato K, Urist MR. Bone morphogenetic protein-induced cartilage development in tissue culture. Clin Orthop Relat Res 1984;183:180-7.
  4. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, et al. Novel regulators of bone formation: Molecular clones and activities. Science 1988;242:1528-34. https://doi.org/10.1126/science.3201241
  5. Sampath TK, Reddi AH. Homolgy of bone-inductive proteins from human, monkey, bovine, and rat extracellular matrix. Proc Natl Acad Sci USA 1983;50:6591-95.
  6. Chai Y, Slavkin HC. Biology of bone induction and its clinical applications. Oral Maxillofac Surg Clin North Am 1994;7:739-53.
  7. Wozney JM. Biology and clinical applications of rhBMP-2. In: Lynch SE, Genco RJ, Marx RE, eds. Tissue engineering: applications in maxillofacial surgery and periodontics. Chicago: Quintessence; 1999:103-10.
  8. Komaki M, Katagiri T, Suda T. Bone morphogenetic protein-2 does not alter differentiation pathway of committed progenitors of osteoblasts and chondroblasts. Cell Tissue Res 1996;284:9-17. https://doi.org/10.1007/s004410050562
  9. Nam JH, Park JC, Yu SB, Chung YI, Tae GY, Kim JJ, et al. Bone regeneration with MMP sensitive hyaluronic acid-based hydrogel, rhBMP-2 and nanoparticles in rat calvarial critical size defect (CSD) model. J Korean Assoc Oral Maxillofac Surg 2009;35:137-45.
  10. Geiger M, Li RH, Friess W. Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev 2003;55:1613-29. https://doi.org/10.1016/j.addr.2003.08.010
  11. Lee JH, Kim SM, Park JC, Sung MA, Yu SB, Nam JH, et al. Bone regeneration with hyaluronic acid based hydrogel-nanoparticle complex and rhBMP-2 in rat critical size defect model. Tissue Eng Regen Med 2009;6:730-8.
  12. Sakiyama-Elbert SE, Hubbell JA. Development of fibrin derivatives for controlled release of heparin-binding growth factors. J Control Release 2000;65:389-402. https://doi.org/10.1016/S0168-3659(99)00221-7
  13. Kim HD, Valentini RF. Retention and activity of BMP-2 in hyaluronic acid-based scaffolds in vitro. J Biomed Mater Res 2002;59:573-84. https://doi.org/10.1002/jbm.10011
  14. Chung YI, Ahn KM, Jeon SH, Lee SY, Lee JH, Tae G. Enhanced bone regeneration with BMP-2 loaded functional nanoparticlehydrogel complex. J Control Release 2007;121:91-9. https://doi.org/10.1016/j.jconrel.2007.05.029
  15. Saito N, Okada T, Horiuchi H, Ota H, Takahashi J, Murakami N, et al. Local bone formation by injection of recombinant human bone morphogenetic protein-2 contained in polymer carriers. Bone 2003;32:381-6. https://doi.org/10.1016/S8756-3282(03)00028-0
  16. Boyan BD, Lohmann CH, Somers A, Niederauer GG, Wozney JM, Dean DD, et al. Potential of porous poly-D,L-lactide-co-glycolide particles as a carrier for recombinant human bone morphogenetic protein-2 during osteoinduction in vivo. J Biomed Mater Res 1999;46:51-9. https://doi.org/10.1002/(SICI)1097-4636(199907)46:1<51::AID-JBM6>3.0.CO;2-I
  17. Sung HJ, Meredith C, Johnson C, Galis ZS. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. Biomaterials 2004;25:5735-42. https://doi.org/10.1016/j.biomaterials.2004.01.066
  18. Dal Pra I, Freddi G, Minic J, Chiarini A, Armato U. De novo engineering of reticular connective tissue in vivo by silk fibroin nonwoven materials. Biomaterials 2005;26:1987-99. https://doi.org/10.1016/j.biomaterials.2004.06.036
  19. Horan RL, Antle K, Collette AL, Wang Y, Huang J, Moreau JE, et al. In vitro degradation of silk fibroin. Biomaterials 2005;26:3385-93. https://doi.org/10.1016/j.biomaterials.2004.09.020
  20. Gosline JM, DeMont ME, Denny MW. The structure and properties of spider silk. Endeavour 1986;10:37-43. https://doi.org/10.1016/0160-9327(86)90049-9
  21. Furuzono T, Ueki M, Kitamura H, Oka K, Imai E. Histological reaction of sintered nanohydroxyapatite-coated cuff and its fibroblast- like cell hybrid for an indwelling catheter. J Biomed Mater Res Part B Appl Biomater 2009;89:77-85.
  22. Wang Y, Blasioli DJ, Kim HJ, Kim HS, Kaplan DL. Cartilage tissue engineering with silk scaffolds and human articular chondrocytes. Biomaterials 2006;27:4434-42. https://doi.org/10.1016/j.biomaterials.2006.03.050
  23. Kirker-Head C, Karageorgiou V, Hofmann S, Fajardo R, Betz O, Merkle HP, et al. BMP-silk composite matrices heal critically sized femoral defects. Bone 2007;41:247-55. https://doi.org/10.1016/j.bone.2007.04.186
  24. Karageourgiou V, Tomkins M, Fajardo R, Meinel L, Snyder B, Wade K, et al. Porous silk fibroin 3-D scaffolds for delivery of bone morphogenetic protein-2 in vitro and in vivo. J Biomed Mater Res A 2006;78:324-34.
  25. Meinel L, Fajardo R, Hofmann S, Langer R, Chen J, Snyder B, et al. Silk implants for the healing of critical size bone defects. Bone 2005;37:688-98. https://doi.org/10.1016/j.bone.2005.06.010
  26. Jang ES, Park JW, Kweon H, Lee KG, Kang SW, Baek DH, et al. Restoration of peri-implant defects in immediate implant installations by Choukroun platelet-rich-fibroin and silk fibroin powder combination graft. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;109:831-6. https://doi.org/10.1016/j.tripleo.2009.10.038
  27. Lee EH, Kim JY, Kweon HY, Jo YY, Min SK, Park YW, et al. A combination graft of low-molecular-weight silk fibroin with Choukroun platelet-rich fibrin for rabbit calvarial defect, Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109:e33-8.
  28. Kim JY, Choi JY, Jeong JH, Jang ES, Kim AS, Kim SG, et al. Low molecular weight silk fibroin increases alkaline phosphatase and type I collagen expression in MG63 cells. BMB Rep 2010;43:52-6. https://doi.org/10.5483/BMBRep.2010.43.1.052
  29. Minoura N, Tsukada M, Nagura M. Fine structure and oxygen permeability of silk fibroin membrane treated with methanol. Polymer 1990;31:265-9. https://doi.org/10.1016/0032-3861(90)90117-H
  30. Santin M, Motta A, Freddi G, Cannas M. In vitro evaluation of the inflammatory potential of the silk fibroin. J Biomed Mater Res 1999;46:382-9. https://doi.org/10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
  31. Cao Y, Wang B. Biodegradation of silk biomaterials. Int J Mol Sci 2009;10:1514-24. https://doi.org/10.3390/ijms10041514
  32. Zhao J, Zhang Z, Wang S, Sun X, Zhang X, Chen J, et al. Apatite-coated silk fibroin scaffolds to healing mandibular border defects in canines. Bone 2009;45:517-27. https://doi.org/10.1016/j.bone.2009.05.026
  33. Kino R, Ikoma T, Yunoki S, Nagai N, Tanaka J, Asakura T, et al. Preparation and characterization of multilayered hydroxyapatite/silk fibroin film. J Biosci Bioeng 2007;103:514- 20. https://doi.org/10.1263/jbb.103.514
  34. Zhao Y, Chen J, Chou AH, Li G, LeGeros RZ. Nonwoven silk fibroin net/nano-hydroxyapatite scaffold: preparation and characteristics. J Biomed Mater Res A 2010;91:1140-9.

피인용 문헌

  1. Bone regeneration by bone morphogenetic protein-2 from porous beads with leaf-stacked structure for critical-sized femur defect model in dogs vol.34, pp.10, 2020, https://doi.org/10.1177/0885328220910033